Abstract
The recent years have seen the emergence of diseases which have spread very quickly all around the world either through human travels like SARS or animal migration like avian flu. Among the biggest challenges raised by infectious emerging diseases, one is related to the constant mutation of the viruses which turns them into continuously moving targets for drug and vaccine discovery. Another challenge is related to the early detection and surveillance of the diseases as new cases can appear just anywhere due to the globalization of exchanges and the circulation of people and animals around the earth, as recently demonstrated by the avian flu epidemics. For 3 years now, a collaboration of teams in Europe and Asia has been exploring some innovative in silico approaches to better tackle avian flu taking advantage of the very large computing resources available on international grid infrastructures. Grids were used to study the impact of mutations on the effectiveness of existing drugs against H5N1 and to find potentially new leads active on mutated strains. Grids allow also the integration of distributed data in a completely secured way. The paper proposes new approaches for the integration of existing data sources towards a global surveillance network for molecular epidemiology and in silico drug discovery.
Keywords: Avian flu, grid, surveillance network, virtual screening, molecular epidemiology
Infectious Disorders - Drug Targets
Title: Innovative In Silico Approaches to Address Avian Flu Using Grid Technology
Volume: 9 Issue: 3
Author(s): Vincent Breton, Ana Lucia da Costa, Paul de Vlieger, Young-Min Kim, Lydia Maigne, Romain Reuillon, David Sarramia, Nam Hai Truong, Hong Quang Nguyen, Doman Kim and Yin-Ta Wu
Affiliation:
Keywords: Avian flu, grid, surveillance network, virtual screening, molecular epidemiology
Abstract: The recent years have seen the emergence of diseases which have spread very quickly all around the world either through human travels like SARS or animal migration like avian flu. Among the biggest challenges raised by infectious emerging diseases, one is related to the constant mutation of the viruses which turns them into continuously moving targets for drug and vaccine discovery. Another challenge is related to the early detection and surveillance of the diseases as new cases can appear just anywhere due to the globalization of exchanges and the circulation of people and animals around the earth, as recently demonstrated by the avian flu epidemics. For 3 years now, a collaboration of teams in Europe and Asia has been exploring some innovative in silico approaches to better tackle avian flu taking advantage of the very large computing resources available on international grid infrastructures. Grids were used to study the impact of mutations on the effectiveness of existing drugs against H5N1 and to find potentially new leads active on mutated strains. Grids allow also the integration of distributed data in a completely secured way. The paper proposes new approaches for the integration of existing data sources towards a global surveillance network for molecular epidemiology and in silico drug discovery.
Export Options
About this article
Cite this article as:
Breton Vincent, da Costa Lucia Ana, de Vlieger Paul, Kim Young-Min, Maigne Lydia, Reuillon Romain, Sarramia David, Truong Hai Nam, Nguyen Quang Hong, Kim Doman and Wu Yin-Ta, Innovative In Silico Approaches to Address Avian Flu Using Grid Technology, Infectious Disorders - Drug Targets 2009; 9 (3) . https://dx.doi.org/10.2174/1871526510909030358
DOI https://dx.doi.org/10.2174/1871526510909030358 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mucoadhesive Buccal Systems as a Novel Strategy for Anti-Inflammatory Drugs Administration
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Histone Acetylation as a Potential Therapeutic Target in Motor Neuron Degenerative Diseases
Current Pharmaceutical Design Piecing the Fragments Together: Dynamical Insights into the Enhancement of BRD4-BD1 (BET Protein) Druggability in Cancer Chemotherapy Using Novel 8-methyl-pyrrolo[1,2-a]pyrazin-1(2H)-one Derivatives
Current Pharmaceutical Biotechnology Current Options and Perspectives in the Treatment of Diabetic Neuropathy
Current Pharmaceutical Design Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches
Current Pharmaceutical Design Neopterin as a Marker for Immune System Activation
Current Drug Metabolism Clostridial Neurotoxins: Mode of Substrate Recognition and Novel Therapy Development
Current Protein & Peptide Science Neurodegeneration in Amygdala Precedes Hippocampus in the APPswe/ PS1dE9 Mouse Model of Alzheimer’s Disease
Current Alzheimer Research Road From Nose to Brain for Treatment of Alzheimer: The Bumps and Humps
CNS & Neurological Disorders - Drug Targets Chitosan Applications on Pharmaceutical Sciences: A Review
Drug Delivery Letters NGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment
Current Medicinal Chemistry Modulation of Response to Audiovisual Stimuli Presented Peripherally by Visually Cued Endogenous Temporal Attention: An Event-Related Potentials Study
Neuroscience and Biomedical Engineering (Discontinued) Novel Thermosensitive Pentablock Copolymers for Sustained Delivery of Proteins in the Treatment of Posterior Segment Diseases
Protein & Peptide Letters Functional Neuroanatomy of the Noradrenergic Locus Coeruleus: Its Roles in the Regulation of Arousal and Autonomic Function Part I: Principles of Functional Organisation
Current Neuropharmacology Emerging Roles of Cysteine Cathepsins in Disease and their Potential as Drug Targets
Current Pharmaceutical Design Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued) Delayed Neuroleptic Malignant Syndrome Associated with the Use of Low Dose Risperidone in Conjunction with Cholinergic Drugs-the Dangers of Polypharmacy in the Elderly
Current Drug Therapy Advances in Inhibitors of FXa
Current Drug Targets Molecular Dynamics Simulation in RNA Interference
Current Medicinal Chemistry Membrane Interacting Peptides: A Review
Current Protein & Peptide Science